Antimicrobial Resistance: The Unfolding Pandemic

Abstract In 1928, Alexander Fleming accidentally discovered penicillin, which was followed by the subsequent work of Sir Howard Florey and Ernst Chain in the early 1940s. The golden age of infectious disease management had just begun, or so it was taught. However, this triumph was short-lived; within a few years, the first resistant organism was isolated. That initial resistance has snowballed, leading to an annual record of 35,000 deaths in the USA and a global death toll of 1.27 million in 2019. By 2050, the world may face an additional US$1 trillion in healthcare costs. Microbial organisms seem to be outpacing researchers; their intrinsic and acquired ability to evade drugs that once killed or inactivated them is alarming, placing global health institutions and scientists under immense pressure. The way forward requires a shift in approach. Timely and accurate diagnosis of AMR organisms is a critical component. Developing rapid diagnostic test kits will enable real-time infection control decisions to prevent community spread, while the continuous advancement of vaccines will foster herd immunity. Stricter policies to eliminate over-the-counter and unauthorized purchases of antimicrobial agents are necessary to mitigate this “unfolding pandemic.” Furthermore, as antimicrobial use in agriculture rises globally, concerted efforts must be made to control this practice, as AMR organisms are evidently transferred from animals to humans. In conclusion, combining the social determinants of health with a biomedical approach is the best path forward; until all nations are protected, no nation is truly safe. Sustained advocacy regarding the dangers of antimicrobial abuse, alongside research into rapid diagnostic kits and vaccines, is essential to mitigate these growing threats.